. Discussion to: Induction chemoimmunotherapy with surgery versus concurrent chemoradiation followed by immunotherapy for stage III-N2 non-small cell lung cancer. J Thorac Cardiovasc Surg 2023 Nov 28:S0022-5223(23)00992.
PMID: 38032558